News & Announcements
ATS Journals have waived submission fees.
The 2024 impact factors are now available.
In recognition of their exemplary work, the Annals editors are delighted to present the 2024 Journal Reviewer Award winners.
This page highlights the top COVID-19 papers of 2020 from each of the four ATS Journals. The items below were selected by the Editor-in-Chief for each of the journals and are meant to showcase some of the most important and relevant COVID-19 content published in AJRCCM, AJRCMB, AnnalsATS, and ATS Scholar.
COVID-19 is a new form of Coronavirus disease due to the novel virus SARS-CoV2 that causes acute infection with respiratory symptoms. This page will serve as a hub for all COVID-19 related manuscripts published across all four ATS Journals.
Current Issue Highlights
The Arizona ECMO Protocol centralized and coordinated evaluation of ECMO transfer requests in a large state with populations in rural areas and with significant geographic, racial, ethnic, and financial diversity at a time when the health system was operating under extreme stress. This protocol involved the successful collaboration of five ECMO programs and public health to centralize a reproducible process to enhance equitable access to a life-saving scarce resource during overwhelming healthcare strain.
OCTOBER 2024 AnnalsATS
Results in this study suggest that early initiation of antifibrotics is associated with lower mortality risk. This finding has important clinical implications because it suggests that antifibrotics should be initiated as soon as a diagnosis of IPF is made.
OCTOBER 2024 AnnalsATS
Changing the reference equation could affect access to treatment and disability benefits, depending on race. If adopted, the use of discrete clinical thresholds needs to be reassessed, considering patient-centered outcomes.
OCTOBER 2024 AnnalsATS